Ashton Tweed

Let’s continue our trip down memory lane for Ashton Tweed’s 20th Birthday with this insightful conversation with Jim Caruso, President & CEO of Cellectar Biosciences, Inc. Jim has been a key executive at organizations of all sizes, from Big Pharma to small specialty companies to start-ups. For over 9 years, Jim has been CEO of Cellectar Biosciences, a publicly traded oncology-focused biopharmaceutical company. Check out this interview we had with him for insight into: 🧬 The Transition from Big Pharma to Start-Up 🤩 How Best to Influence a Company’s Culture 🔬 How Technology Can Attract Top Executives 👍 Importance of Recognizing People 🥇 The Biggest Lessons He’s Learned in His Career This Executive Leadership Interview is a goldmine for anyone in (or aspiring to be in) the Life Sciences. Read it all: https://lnkd.in/euvGrRQr

🥳🎊 Ashton Tweed would like to take a moment to shout out and thank our first-ever Executive Leadership Series interviewee: Jane Hollingsworth! 🎊🥳 Over the last two decades, our Executive Leadership interviews are one of AT’s biggest points of pride. They offer insight into timeless advice from some of Life Sciences’ most successful minds. These articles also demonstrate moments in time to look back on years later to understand the biggest trends in Life Sciences over a decade ago. Take some time to look back to 2011, when Jane Hollingsworth offered her perspective on: 💸 How to overcome financial challenges in developing specialty pharmaceuticals 👩🏽💼👨🏻💼What it takes to build a winning Life Sciences team 🚀Lessons learned in taking a specialty pharmaceutical company public This interview was conducted on the cusp of NuPathe’s first product approval, and the company went on to be acquired by Teva in 2014. Take a trip back to 2011: https://lnkd.in/dt84xzVn

Many of the biggest Life Sciences industry events in the last year returned to full, in-person capacity. Do you know if your networking skills are still sharp? 🤔⚡ Keeping up with our nostalgic look back on Ashton Tweed’s 20 years of service to the Life Sciences community, now is the best time to highlight a helpful article by one of our founders, Jordan Warshafsky: 🤦♂️‼️ The Top 11 Networking Mistakes! ‼️🤦♂️ It’s still just as relevant today as it was in 2014, including mistakes like: 👍 Not going beyond social media networking 💬 Talking too much 📅 Failing to follow-up ➕ And more! Whether you’re starting your networking journey or shaking off the dust post-pandemic, check it out here: https://lnkd.in/eZ6cykdT

📈👨🏿💼 An Executive Search is an investment in long-term growth for your organization. When you have a business-critical opening, Executive Search will uncover a shortlist of great qualified talent. 👩🏻💼📈 Since 2023, AT's average time to identify the candidate who will eventually be placed has been within one week of researching. As Ashton Tweed continues to commemorate our 20th Anniversary, we would like to celebrate a few of the many talented people we've placed in the last two decades: 🔬 2013 - Ashton Tweed placed a Plant Manager at a midsize, advanced biotech materials group who eventually became the Chief Operations Officer after a decade there. 👩🔬 2017 - We found a new Sr. Director of Engineering for a prominent MedTech company who has since become their Head of Engineering 💼 2017 - An intelligent Healthcare platform company needed a Chief Commercial Officer. Our placement led the company as its new President a year into their time there. 🤝 2019 - AT filled a Sr. Director of Business Development for a large CDMO who has gone on to become their VP of Sales & BD 💊 2022 - Ashton Tweed confidentially worked to place a General Manager tasked with running the US for a large international pharmaceutical company that is now flourishing 🧬 2023 - We uncovered a new General Manager for a worldwide biopharma who came in to successfully lead the company's US operations as they pivoted to a new therapeutic area post-asset acquisition. If you're looking for high-level talent to fill a crucial spot on your org chart or are hunting for your next permanent role, contact any of our Ashton Tweed team members here on LinkedIn. We’d love to hear from you! Learn more about Executive Search here: https://lnkd.in/e7QkuUYb

🙌 To continue Ashton Tweed’s 20th Anniversary Celebration, let’s look back to an important conversation we had in 2020. 🙌 We hosted a panel of women in Life Sciences leadership positions, moderated by Debbie Hart of BioNJ, to discuss a wide range of issues female leaders face regularly in the workplace – that’s still just as relevant today. In this insightful conversation, Elizabeth Garner, Elizabeth (Betsy) Hanna, Jane Hollingsworth, and Michele Korfin touch on: 👩💼 Gender discrimination and how they’ve dealt with it in their careers 📚 Unique skills aspiring female leaders can learn to better navigate Life Sciences 🚸 The expectation of women to still bear more family care responsibility 🧗♀️ Disproportionate promotions between men and women 👔 Advice for male executives who want to be more supportive of women ➕ Much more! You can read the full discussion here: https://lnkd.in/eVyx9Kh

🤯 Did you know you can fill business-critical spots on your org chart with interim talent in as little as 15 days? 🤯 You may know Asthon Tweed as a Retained Search firm. However, in the past two decades of placing highly experienced fractional leaders into organizations to work on immediate assignments, we've found: ⏱️ Interim hiring is the quickest way to attract exceptional talent from the C-suite through VP/Senior-level specialized roles for hard-to-fill positions 📊 Interim Talent is utilized by over 60% of our clients 💰 Interim & Fractional hiring can be an essential tool to conserve cash during difficult funding periods 👩🏾💼 Interim work is an excellent steppingstone for senior talent towards a full-time consulting career 📈 It's a fully scalable talent solution to drive business forward 💼 20% of our Interim assignments have turned into permanent hires The best way to learn more about bringing in qualified interim talent on a fixed duration basis or get started in interim work is to reach out to Ashton Tweed here on LinkedIn or our website https://lnkd.in/eDsnGikE

In 2019, we sat down with Martin Lehr of Context Therapeutics to learn how his new point of view could lead to a novel treatment for hormone-driven cancers. Since then, Context has grown exponentially - recently securing $100M to advance clinical trials earlier this year. We continue AT’s 20th Anniversary by looking back at Martin’s 2019 Executive Leadership Series, as he details: 🔬What brought him to Oncology in the first place 📈Efficiency and cost-effectiveness of an Investigator Run Clinical Program 👤 Importance of keeping a stealthier approach before going to investors with new data 🤝🏻Social pacts between biopharmaceutical companies, investors, and – ultimately – patients Read more here: https://lnkd.in/ehfnRUE

🎉 ✨ Ashton Tweed Celebrates Its 20th Anniversary ✨🎉 We want to take this time to extend a sincere thank you to all our friends in the Life Sciences community for your support! In 2004, Ashton Tweed started with three core goals: 🤝🏻 Place highly qualified candidates in key roles for top Life Sciences companies – Ensuring both candidate and client are equally satisfied 💻 Build a Life Sciences Talent Bank for Executive Search - To ease the search process, resulting in high-quality and efficient placements 📅 Pioneer Interim Executive placements - Fill crucial openings with just-in-time talent to solve critical business needs In the past two decades, we’ve blossomed into a go-to resource for biotech, pharma, medical device, diagnostic, and service companies, from new start-ups to global corporations – and it’s thanks to folks like you. If you've ever utilized Ashton Tweed to find talent, been placed by Ashton Tweed, or even just taken the time to read our Executive Leadership Series in the past - thank you! 🌟 Be sure to follow us here on LinkedIn in the coming weeks as we close out our 20th-year celebration with helpful info, tips, and tricks on executive search and Life Sciences leadership in 2024 and beyond. 🌟